Differences

This shows you the differences between two versions of the page.

--- home:diseases:lyme [08.12.2019] – [1 MP patient to try] sallieq
+++ home:diseases:lyme [08.12.2019] – sallieq
@@ Line 44: / Line 44: @@
 What we who are a part of this forum, who stuck with the protocol long enough, who endured the IP and were able to keep a doctor, report is that this has a better than 50% success rate.
-===== Other treatments =====
-  * **[[home:othertreatments:colloidal_silver|colloidal silver]]** – While colloidal silver is marketed for internal and external use as an alternative medical remedy, there is no scientific evidence of its effectiveness in vivo for any medical condition. Also, it can [[http://www.quackwatch.org/01QuackeryRelatedTopics/PhonyAds/silverad.html|permanently turn]] your skin silver.
-  * **hydrogen peroxide** – Delivered intravenously. The theory is that hydrogen peroxide releases extra oxygen inside the body, killing microbes. This [[http://www.cbsnews.com/stories/2005/01/12/60II/main666489.shtml|dangerous therapy]] is based on an overly simplistic view of the body's metabolism. There are no large-scale studies proving hydrogen peroxide is effective.
-  * **[[home:othertreatments:rife|Rife]]** – There is no scientific evidence that the use of a Rife device has the intended effect on infectious bacteria. Instead, most patients using Rife are likely administering themselves nothing more than an expensive placebo.
-Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi. Some highly active essential oils were found to have excellent anti-biofilm ability  (({{pubmed>long:    29075628}}))
-==== Disulfiram ====
-[[https://www.lymedisease.org/disulfiram-kinderlehrer/?fbclid=IwAR2CQcqG97LK_qsGh1QZD37VrD2oQecR70cZKyXlidgdMIyGOWcPgKdLAWA|Activity of disulfiram]]
-[[https://www.mdpi.com/2079-6382/8/2/72/htm?fbclid=IwAR3l19rcHXqfvUcYXUqlk9F18kZqwGX_QsiJPdgfPrIUYe15SUAAGKltfTo|Three cases]]
-[[https://clinicaltrials.gov/ct2/show/NCT03891667|Study to examine the safety of disulfiram among patients with post-treatment Lyme disease Sx]]
-Screening to identify potent candidate drugs that can target the Borrelia persisters.(({{pubmed>long:27103785}}))
-Not suitable for children (({{pubmed>long:6470872}})), (({{pubmed>long:9093309}}))
-May be for adolescents (({{pubmed>long:27613346}}))
-===   ===
-<blockquote>My doc just prescribed this for me but with a big warning to ramp VERY slowly due to immunopathology, IP/ Herx can be powerful.
-I have not filled the script yet but will update my progress thread if/ when I embark on this method.</blockquote>
-=====Antibiotic treatments=====
-<mainarticle>  [[home:othertreatments:antibacterials:highdose|High-dose antibiotic therapies]]</article>
-One of the reasons why chronic Lyme disease is so contentious is that advocates for it strongly believe in the value of high-dose antibiotic therapies, any treatment which uses antibiotics at a large enough dose that the immune response is suppressed more than it is not. High-dose antibiotics are ineffective, and this is well-reflected in the published literature. The short-term improvement and long-term crash some patients feel on high-dose antibiotics is due to the fact these drugs interfere with immune activity in dose dependent fashion. With a weakened inflammatory response, a patient's symptoms may temporarily improve, but not because the pathogenic bacteria which drive disease have been eradicated. As a result, these protocols do not generate sustained immunopathology.
-=== Doxycycline ===
-<mainarticle> [[home:othertreatments:antibacterials:doxycycline|Doxycycline]]</article>
-Although the MP antibiotic minocycline is also a tetracycline, doxycycline and minocycline are significantly different from each other – both in terms of structure and function. Doxycycline's effectiveness over short periods of time is due in part to the relatively high doses at which it is typically administered: 200 mg per day. Doxycycline does not kill as wide a range of bacteria as minocycline. For example, doxycycline doesn't kill //Staphylococcus//, a genus found in at least three recent studies in which the human microbiome was sequenced.
-=== Cephlasporins including Rocephin ===
-<mainarticle> [[home:othertreatments:antibacterials:betalactams|Beta-lactam antibiotics]]</article>
-{{section>:home:othertreatments:antibacterials:betalactams#cephalosporins&noheader&firstseconly}}
-==== Multiple ABx ====
-[[http://www.discoverymedicine.com/Jie-Feng/2019/03/persister-biofilm-microcolony-borrelia-burgdorferi-causes-severe-lyme-arthritis-in-mouse-model/|persistent disease: compared efficacy of 2-drug and 3-drug combination]]
-Those affected by persistent Lyme disease, who are unable to follow the Marshall Protocol, may benefit from inquiring into the use of **3** antibiotic drugs in combination
- the combination of different antiborrelial agents with synergistic effect seems to be a meaningful alternative and should be included in future studies in vitro as well as in vivo.(({{pubmed>long:    12073540}}))
-Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.  (({{pubmed>long:    25806811}}))
-Sulpha drugs and their combinations(({{pubmed>long:28327498}}))
 ===== Role of infection =====
@@ Line 158: / Line 106: @@
 One of the significant distinctions between a herx reaction in patients taking high-dose antibiotics and those on the MP is the length of that reaction. While it is common to hear Lyme patients experience a herx response for several weeks, patients on the MP may experience sustained immunopathology over the course of years. While this makes the MP harder to complete, the length of the treatment before a decrease in symptoms may be a tribute to how sick some patients with chronic Lyme or any other chronic disease truly are.
-=====Chronic controversy over chronic Lyme disease =====
-<blockquote>Lyme disease, with 20,000 cases reported annually, ranks low on the list of the most prevalent infectious diseases. But it ranks first in rancor generated in the medical community.
-//**David Whelan** wrote //  Ticks aren't the only parasites living off patients in borreliosis-prone areas
-</blockquote>
-While there is general agreement on the optimal treatment for early Lyme disease, there is considerable controversy over the existence, prevalence, diagnostic criteria, and treatment of chronic Lyme disease.
-Over the past decade, two opposing camps have emerged in the battle over Lyme. One camp is represented by the International Lyme and Associated Diseases Society (ILADS), which argues that Lyme disease is not rare because its spread is facilitated by rodents, deer and birds, and can be found in an unpredictable distribution around the world accompanied by other tick-borne coinfections that may complicate the clinical presentation. According to the ILADS, tick bites often go unnoticed and commercial laboratory testing for Lyme disease is inaccurate. Consequently, the disease is often not recognized and may persist in a large number of patients, requiring prolonged antibiotic therapy to eradicate persistent infection with the evasive Lyme spirochete.(({{pubmed>long:19072179}}))
-The opposing camp is represented by the Infectious Diseases Society of America (IDSA), which maintains that Lyme disease is a rare illness localized to well-defined areas of the world. According to the IDSA, the disease is "hard to catch and easy to cure" because the infection is rarely encountered, easily diagnosed in its early stage by distinctive clinical features and in more advanced stages by accurate commercial laboratory tests, and effectively treated with a short course of antibiotics over 2-4 weeks. Chronic infection with the Lyme spirochete, //Borrelia burgdorferi//, is rare or nonexistent, and the concept of chronic Lyme disease rests on "faith-based" opinion rather than "evidence-based" science.(({{pubmed>long:19072179}}))
-This mainstream view is exemplified by a 2007 review in the //New England Journal of Medicine//, which noted the diagnosis of chronic Lyme disease is used by a few physicians despite a lack of "reproducible or convincing scientific evidence", leading the authors to describe this diagnosis as "the latest in a series of syndromes that have been postulated in an attempt to attribute medically unexplained symptoms to particular infections."(({{pubmed>long:17914043}}))
-<blockquote>Chronic Lyme disease is the most recent in a continuing series of "medically unexplained symptoms" syndromes. These syndromes, such as fibromyalgia, chronic fatigue syndrome, and multiple chemical sensitivity, meet the need for a societally and morally acceptable explanation for ill-defined symptoms in the absence of objective physical and laboratory findings. We describe factors involved in the psychopathogenesis of chronic Lyme disease and focus on the confusion and insecurity these patients feel, which gives rise to an inability to adequately formulate and articulate their health concerns and to deal adequately with their medical needs, a state of disorganization termed aporia.
-//**L.H. Sigal**// (({{pubmed>long:12194894}})) </blockquote>
-Groups of patients, patient advocates, and the small number of physicians who support the concept of chronic Lyme disease have organized to lobby for recognition of this diagnosis, as well as to argue for insurance coverage of long-term antibiotic therapy, which most insurers deny, as it is at odds with the guidelines of the major medical organizations.
-The term "Lyme-literate medical doctor" or LLMD has been coined to describe physicians who acknowledge the existence of chronic Lyme disease an infectious condition and are willing to treat it with antimicrobial therapies. LLMDs generally operate outside the mainstream of medicine. A number have been brought up before medical board reviews and been the subject of patient lawsuits.
-The net result of this controversy is that many doctors [[http://www.ama-assn.org/amednews/2008/06/09/hlsa0609.htm|try to avoid]] having Lyme patients in their practice.
-===== Research =====
- Many antimicrobial agents (antibiotics, antivirals, antifungals, anthelmintics or antiparasitics) used for treating other infections were found to have better activity than the current Lyme antibiotics. These include antibacterials such as rifamycins (3-formal-rifamycin, rifaximin, rifamycin SV), thiostrepton, quinolone drugs (sarafloxacin, clinafloxacin, tosufloxacin), and cell wall inhibitors carbenicillin, tazobactam, aztreonam; antifungal agents such as fluconazole, mepartricin, bifonazole, climbazole, oxiconazole, nystatin; antiviral agents zanamivir, nevirapine, tilorone; antimalarial agents artemisinin, methylene blue, and quidaldine blue; antihelmintic and antiparasitic agents toltrazuril, tartar emetic, potassium antimonyl tartrate trihydrate, oxantel, closantel, hycanthone, pyrimethamine, and tetramisole. Interestingly, drugs used for treating other non-infectious conditions including verteporfin, oltipraz, pyroglutamic acid, pidolic acid, and dextrorphan tartrate, that act on the glutathione/γ-glutamyl pathway involved in protection against free radical damage, and also the antidepressant drug indatraline, were found to have high activity against stationary phase B. burgdorferi.  (({{pubmed>long:    27025631}}))
@@ Line 297: / Line 207: @@
 </blockquote>
+===== Research =====
+ Many antimicrobial agents (antibiotics, antivirals, antifungals, anthelmintics or antiparasitics) used for treating other infections were found to have better activity than the current Lyme antibiotics. These include antibacterials such as rifamycins (3-formal-rifamycin, rifaximin, rifamycin SV), thiostrepton, quinolone drugs (sarafloxacin, clinafloxacin, tosufloxacin), and cell wall inhibitors carbenicillin, tazobactam, aztreonam; antifungal agents such as fluconazole, mepartricin, bifonazole, climbazole, oxiconazole, nystatin; antiviral agents zanamivir, nevirapine, tilorone; antimalarial agents artemisinin, methylene blue, and quidaldine blue; antihelmintic and antiparasitic agents toltrazuril, tartar emetic, potassium antimonyl tartrate trihydrate, oxantel, closantel, hycanthone, pyrimethamine, and tetramisole. Interestingly, drugs used for treating other non-infectious conditions including verteporfin, oltipraz, pyroglutamic acid, pidolic acid, and dextrorphan tartrate, that act on the glutathione/γ-glutamyl pathway involved in protection against free radical damage, and also the antidepressant drug indatraline, were found to have high activity against stationary phase B. burgdorferi.  (({{pubmed>long:    27025631}}))
 ===== Read more =====
@@ Line 306: / Line 219: @@
+=====Chronic controversy over chronic Lyme disease =====
+<blockquote>Lyme disease, with 20,000 cases reported annually, ranks low on the list of the most prevalent infectious diseases. But it ranks first in rancor generated in the medical community.
+//**David Whelan** wrote //  Ticks aren't the only parasites living off patients in borreliosis-prone areas
+</blockquote>
+While there is general agreement on the optimal treatment for early Lyme disease, there is considerable controversy over the existence, prevalence, diagnostic criteria, and treatment of chronic Lyme disease.
+Over the past decade, two opposing camps have emerged in the battle over Lyme. One camp is represented by the International Lyme and Associated Diseases Society (ILADS), which argues that Lyme disease is not rare because its spread is facilitated by rodents, deer and birds, and can be found in an unpredictable distribution around the world accompanied by other tick-borne coinfections that may complicate the clinical presentation. According to the ILADS, tick bites often go unnoticed and commercial laboratory testing for Lyme disease is inaccurate. Consequently, the disease is often not recognized and may persist in a large number of patients, requiring prolonged antibiotic therapy to eradicate persistent infection with the evasive Lyme spirochete.(({{pubmed>long:19072179}}))
+The opposing camp is represented by the Infectious Diseases Society of America (IDSA), which maintains that Lyme disease is a rare illness localized to well-defined areas of the world. According to the IDSA, the disease is "hard to catch and easy to cure" because the infection is rarely encountered, easily diagnosed in its early stage by distinctive clinical features and in more advanced stages by accurate commercial laboratory tests, and effectively treated with a short course of antibiotics over 2-4 weeks. Chronic infection with the Lyme spirochete, //Borrelia burgdorferi//, is rare or nonexistent, and the concept of chronic Lyme disease rests on "faith-based" opinion rather than "evidence-based" science.(({{pubmed>long:19072179}}))
+This mainstream view is exemplified by a 2007 review in the //New England Journal of Medicine//, which noted the diagnosis of chronic Lyme disease is used by a few physicians despite a lack of "reproducible or convincing scientific evidence", leading the authors to describe this diagnosis as "the latest in a series of syndromes that have been postulated in an attempt to attribute medically unexplained symptoms to particular infections."(({{pubmed>long:17914043}}))
+<blockquote>Chronic Lyme disease is the most recent in a continuing series of "medically unexplained symptoms" syndromes. These syndromes, such as fibromyalgia, chronic fatigue syndrome, and multiple chemical sensitivity, meet the need for a societally and morally acceptable explanation for ill-defined symptoms in the absence of objective physical and laboratory findings. We describe factors involved in the psychopathogenesis of chronic Lyme disease and focus on the confusion and insecurity these patients feel, which gives rise to an inability to adequately formulate and articulate their health concerns and to deal adequately with their medical needs, a state of disorganization termed aporia.
+//**L.H. Sigal**// (({{pubmed>long:12194894}})) </blockquote>
+Groups of patients, patient advocates, and the small number of physicians who support the concept of chronic Lyme disease have organized to lobby for recognition of this diagnosis, as well as to argue for insurance coverage of long-term antibiotic therapy, which most insurers deny, as it is at odds with the guidelines of the major medical organizations.
+The term "Lyme-literate medical doctor" or LLMD has been coined to describe physicians who acknowledge the existence of chronic Lyme disease an infectious condition and are willing to treat it with antimicrobial therapies. LLMDs generally operate outside the mainstream of medicine. A number have been brought up before medical board reviews and been the subject of patient lawsuits.
+The net result of this controversy is that many doctors [[http://www.ama-assn.org/amednews/2008/06/09/hlsa0609.htm|try to avoid]] having Lyme patients in their practice.
 {{tag>diseases}}
@@ Line 449: / Line 385: @@
 Trevor
 </blockquote>
+===== Treatments sometimes used by those not on MP =====
+  * **[[home:othertreatments:colloidal_silver|colloidal silver]]** – While colloidal silver is marketed for internal and external use as an alternative medical remedy, there is no scientific evidence of its effectiveness in vivo for any medical condition. Also, it can [[http://www.quackwatch.org/01QuackeryRelatedTopics/PhonyAds/silverad.html|permanently turn]] your skin silver.
+  * **hydrogen peroxide** – Delivered intravenously. The theory is that hydrogen peroxide releases extra oxygen inside the body, killing microbes. This [[http://www.cbsnews.com/stories/2005/01/12/60II/main666489.shtml|dangerous therapy]] is based on an overly simplistic view of the body's metabolism. There are no large-scale studies proving hydrogen peroxide is effective.
+  * **[[home:othertreatments:rife|Rife]]** – There is no scientific evidence that the use of a Rife device has the intended effect on infectious bacteria. Instead, most patients using Rife are likely administering themselves nothing more than an expensive placebo.
+Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi. Some highly active essential oils were found to have excellent anti-biofilm ability  (({{pubmed>long:    29075628}}))
+==== Disulfiram ====
+[[https://www.lymedisease.org/disulfiram-kinderlehrer/?fbclid=IwAR2CQcqG97LK_qsGh1QZD37VrD2oQecR70cZKyXlidgdMIyGOWcPgKdLAWA|Activity of disulfiram]]
+[[https://www.mdpi.com/2079-6382/8/2/72/htm?fbclid=IwAR3l19rcHXqfvUcYXUqlk9F18kZqwGX_QsiJPdgfPrIUYe15SUAAGKltfTo|Three cases]]
+[[https://clinicaltrials.gov/ct2/show/NCT03891667|Study to examine the safety of disulfiram among patients with post-treatment Lyme disease Sx]]
+Screening to identify potent candidate drugs that can target the Borrelia persisters.(({{pubmed>long:27103785}}))
+Not suitable for children (({{pubmed>long:6470872}})), (({{pubmed>long:9093309}}))
+May be for adolescents (({{pubmed>long:27613346}}))
+===   ===
+<blockquote>My doc just prescribed this for me but with a big warning to ramp VERY slowly due to immunopathology, IP/ Herx can be powerful.
+I have not filled the script yet but will update my progress thread if/ when I embark on this method.</blockquote>
+=====Antibiotic treatments=====
+<mainarticle>  [[home:othertreatments:antibacterials:highdose|High-dose antibiotic therapies]]</article>
+One of the reasons why chronic Lyme disease is so contentious is that advocates for it strongly believe in the value of high-dose antibiotic therapies, any treatment which uses antibiotics at a large enough dose that the immune response is suppressed more than it is not. High-dose antibiotics are ineffective, and this is well-reflected in the published literature. The short-term improvement and long-term crash some patients feel on high-dose antibiotics is due to the fact these drugs interfere with immune activity in dose dependent fashion. With a weakened inflammatory response, a patient's symptoms may temporarily improve, but not because the pathogenic bacteria which drive disease have been eradicated. As a result, these protocols do not generate sustained immunopathology.
+=== Doxycycline ===
+<mainarticle> [[home:othertreatments:antibacterials:doxycycline|Doxycycline]]</article>
+Although the MP antibiotic minocycline is also a tetracycline, doxycycline and minocycline are significantly different from each other – both in terms of structure and function. Doxycycline's effectiveness over short periods of time is due in part to the relatively high doses at which it is typically administered: 200 mg per day. Doxycycline does not kill as wide a range of bacteria as minocycline. For example, doxycycline doesn't kill //Staphylococcus//, a genus found in at least three recent studies in which the human microbiome was sequenced.
+=== Cephlasporins including Rocephin ===
+<mainarticle> [[home:othertreatments:antibacterials:betalactams|Beta-lactam antibiotics]]</article>
+{{section>:home:othertreatments:antibacterials:betalactams#cephalosporins&noheader&firstseconly}}
+==== Multiple Antibiotics ====
+[[http://www.discoverymedicine.com/Jie-Feng/2019/03/persister-biofilm-microcolony-borrelia-burgdorferi-causes-severe-lyme-arthritis-in-mouse-model/|persistent disease: compared efficacy of 2-drug and 3-drug combination]]
+Those affected by persistent Lyme disease, who are unable to follow the Marshall Protocol, may benefit from inquiring into the use of **3** antibiotic drugs in combination
+ the combination of different antiborrelial agents with synergistic effect seems to be a meaningful alternative and should be included in future studies in vitro as well as in vivo.(({{pubmed>long:    12073540}}))
+Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.  (({{pubmed>long:    25806811}}))
+Sulpha drugs and their combinations(({{pubmed>long:28327498}}))
 ===== References =====

home/diseases/lyme.txt · Last modified: 09.14.2022 by 127.0.0.1